Iris Neoplasm — Trials

Iris Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01413191	Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye	completed	Phase 2	18	National Cancer Institute (NCI)NIH	1	Feb 19, 2020	clinicaltrials
NCT01100528	Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance	completed	Phase 2	38	Case Comprehensive Cancer CenterOTHER	1	Feb 26, 2019	clinicaltrials
NCT00121225	Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma	completed	Phase 2	32	National Cancer Institute (NCI)NIH	2	Jan 29, 2019	clinicaltrials
NCT00243061	AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Data updated 22 days agoSource updated Feb 19, 2020source: clinicaltrials